Sara Grehl

509 total citations
10 papers, 429 citations indexed

About

Sara Grehl is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sara Grehl has authored 10 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Sara Grehl's work include Cancer-related Molecular Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers) and DNA Repair Mechanisms (2 papers). Sara Grehl is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers) and DNA Repair Mechanisms (2 papers). Sara Grehl collaborates with scholars based in Germany, United States and New Zealand. Sara Grehl's co-authors include Christoph Pöttgen, Martin Stuschke, S. Levegrün, Ali Sak, Dirk Theegarten, Thomas Gauler, Georgios Stamatis, Simone Marnitz, Gerald Antoch and Wilfried Eberhardt and has published in prestigious journals such as Clinical Cancer Research, Annals of Oncology and The Laryngoscope.

In The Last Decade

Sara Grehl

10 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Grehl Germany 9 187 181 178 120 110 10 429
Lydia Koi Germany 10 84 0.4× 112 0.6× 154 0.9× 150 1.3× 144 1.3× 19 375
Janet Taylor United Kingdom 7 69 0.4× 125 0.7× 259 1.5× 304 2.5× 100 0.9× 10 505
Go Oshima United States 7 54 0.3× 174 1.0× 113 0.6× 146 1.2× 181 1.6× 13 418
Eduardas Aleknavičius Lithuania 10 89 0.5× 78 0.4× 94 0.5× 79 0.7× 101 0.9× 33 386
A.F. Hermens Netherlands 7 184 1.0× 143 0.8× 126 0.7× 85 0.7× 147 1.3× 11 402
Kobe Reynders Netherlands 7 94 0.5× 217 1.2× 60 0.3× 47 0.4× 388 3.5× 12 550
Masakazu Ogura Japan 11 86 0.5× 174 1.0× 61 0.3× 90 0.8× 102 0.9× 29 368
Gabriela Altorjai Austria 12 164 0.9× 222 1.2× 51 0.3× 81 0.7× 366 3.3× 22 545
Rishab Ramapriyan United States 9 48 0.3× 177 1.0× 215 1.2× 184 1.5× 320 2.9× 18 598
Jarob Saker Germany 6 121 0.6× 113 0.6× 157 0.9× 26 0.2× 193 1.8× 7 322

Countries citing papers authored by Sara Grehl

Since Specialization
Citations

This map shows the geographic impact of Sara Grehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Grehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Grehl more than expected).

Fields of papers citing papers by Sara Grehl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Grehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Grehl. The network helps show where Sara Grehl may publish in the future.

Co-authorship network of co-authors of Sara Grehl

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Grehl. A scholar is included among the top collaborators of Sara Grehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Grehl. Sara Grehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lehnerdt, Goetz, Peter Franz, Ágnes Bánkfalvi, et al.. (2009). The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma. Annals of Oncology. 20(6). 1094–1099. 39 indexed citations
2.
Sak, Ali, Sara Grehl, M. Engelhard, et al.. (2009). Long-Term In vivo Effects of Cisplatin on γ-H2AX Foci Signaling in Peripheral Lymphocytes of Tumor Patients After Irradiation. Clinical Cancer Research. 15(8). 2927–2934. 20 indexed citations
3.
Lehnerdt, Goetz, Peter Franz, Ágnes Bánkfalvi, et al.. (2008). The GNAS1 T393C Polymorphism Predicts Survival in Patients With Advanced Squamous Cell Carcinoma of the Larynx. The Laryngoscope. 118(12). 2172–2176. 21 indexed citations
4.
Lehnerdt, Goetz, Peter Franz, Klaus J. Schmitz, et al.. (2008). Overall and Relapse-Free Survival in Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma Are Associated with Genotypes of T393C Polymorphism of the GNAS1 Gene. Clinical Cancer Research. 14(6). 1753–1758. 20 indexed citations
5.
Lehnerdt, Goetz, Ágnes Bánkfalvi, Sara Grehl, et al.. (2008). No Association of the NF-κB1 −94INS/Delattg Promoter Polymorphism with Relapse-Free and Overall Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Region. International Journal of Immunopathology and Pharmacology. 21(4). 827–832. 11 indexed citations
6.
Lehnerdt, Goetz, Peter Franz, Ágnes Bánkfalvi, et al.. (2008). Association Study of the G-Protein β3 Subunit C825T Polymorphism with Disease Progression an Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 17(11). 3203–3207. 10 indexed citations
7.
8.
9.
Pöttgen, Christoph, Martin Stuschke, Georg Stüben, et al.. (2003). Long-Term Survival Following Radiotherapy and Cytarabine Chemotherapy for Sporadic Primary Central Nervous System Lymphoma. Strahlentherapie und Onkologie. 179(9). 626–632. 5 indexed citations
10.
Sak, Ali, Reinhard Würm, Sara Grehl, et al.. (2003). Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21WAF1/CIP1. Cancer Gene Therapy. 10(12). 926–934. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lydia Koi Breakdown of academic impact, for papers by Janet Taylor Breakdown of academic impact, for papers by Go Oshima Breakdown of academic impact, for papers by Eduardas Aleknavičius Breakdown of academic impact, for papers by A.F. Hermens Breakdown of academic impact, for papers by Kobe Reynders Breakdown of academic impact, for papers by Masakazu Ogura Breakdown of academic impact, for papers by Gabriela Altorjai Breakdown of academic impact, for papers by Rishab Ramapriyan Breakdown of academic impact, for papers by Jarob Saker
Rankless by CCL
2026